IL33 and colorectal carcinoma: Our data demonstrate that IL-33 (sensitivity 95.8%, specificity 45.8%) Gal-1 (sensitivity 59.1%, specificity 66.7%) and IL-1 (sensitivity 75%, specificity 75%) can be potential markers for paraneoplastic anemia in CRC patients.